1. Home
  2. MYSZ vs VRAX Comparison

MYSZ vs VRAX Comparison

Compare MYSZ & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

N/A

Current Price

$2.57

Market Cap

2.2M

Sector

Technology

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.89

Market Cap

2.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYSZ
VRAX
Founded
1999
2013
Country
Israel
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.3M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYSZ
VRAX
Price
$2.57
$2.89
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
257.4K
467.5K
Earning Date
04-15-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
57.40
N/A
EPS
N/A
N/A
Revenue
$142,000.00
N/A
Revenue This Year
$41.64
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
N/A
52 Week Low
$0.33
$0.10
52 Week High
$4.28
$13.19

Technical Indicators

Market Signals
Indicator
MYSZ
VRAX
Relative Strength Index (RSI) 69.76 49.11
Support Level $0.52 $0.19
Resistance Level $4.28 $3.10
Average True Range (ATR) 0.35 0.29
MACD 0.06 -0.03
Stochastic Oscillator 56.32 10.76

Price Performance

Historical Comparison
MYSZ
VRAX

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: